...
首页> 外文期刊>BMC Pulmonary Medicine >Novel compound heterozygous mutations of DNAH5 identified in a pediatric patient with Kartagener syndrome: case report and literature review
【24h】

Novel compound heterozygous mutations of DNAH5 identified in a pediatric patient with Kartagener syndrome: case report and literature review

机译:具有Kartericer综合征的小儿患者中鉴定的DNAH5的新化合物杂合突变:病例报告和文献综述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Kartagener syndrome is a subtype of primary ciliary dyskinesia that may exhibit various symptoms including neonatal respiratory distress and frequent infections of the lung, sinus and middle ear because of the impaired function of motile cilia. In addition to typical symptoms of primary ciliary dyskinesia, patients with Kartagener syndrome also show situs inversus. It is an autosomal recessive disorder which is mostly caused by mutations in DNAH5. Kartagener syndrome is often underdiagnosed due to challenges in the diagnosis process. As next-generation sequencing becomes widely used in clinical laboratories, genetic testing provides an accurate approach to the diagnosis of Kartagener syndrome. A 7-year-old female patient presented with runny nose of 6 years duration and recurrent cough with phlegm of 2 years duration. Kartagener syndrome was diagnosed through diagnostic tests such as nasal nitric oxide (NO) concentration and transmission electron microscopy, and after performing other exams that corroborated the diagnosis, such as computed tomography, bronchoscopy and hearing test. Whole-exome sequencing was performed for the patient and both parents. The pediatric patient was diagnosed as Kartagener syndrome with the typical symptoms of ciliary dyskinesia including bronchiectasis, sinusitis, conductive hearing loss and situs inversus along with a reduced nasal NO concentration and ciliary abnormalities. The patient carried two novel compound heterozygous mutations in DNAH5, NM_001369:c.12813G??A (p. Trp4271Term) and NM_001369:c.9365delT (p. Leu3122Term). Both mutations lead to premature stop codons and thus are pathogenic. The p. Trp4271Term and p. Leu3122Term mutations were inherited from the father and the mother of the patient individually. A literature review was also conducted to summarize DNAH5 mutations in pediatric patients with Kartagener syndrome across different ethnic groups. Our study provides a good example of the diagnosis of Kartagener syndrome in pediatric patients using a series of diagnostic tests combined with genetic testing. Two novel loss-of-function mutations in DNAH5 were identified and validated in a pediatric patient with Kartagener syndrome.
机译:Karteragener综合征是主要睫状体障碍的亚型,可能表现出各种症状,包括新生儿呼吸窘迫和由于运动纤毛的功能受损的肺,窦和中耳的频繁感染。除典型睫状体障碍的典型症状外,Kartagener综合症的患者还表明了SITUS Inversus。它是一种常染色体隐性障碍,主要是由DNAH5中的突变引起的。由于诊断过程中的挑战,皇家蛋白综合征通常是由于挑战而受到的。作为下一代测序在临床实验室中广泛应用于临床实验室,遗传检测提供了一种准确的探究性综合征诊断方法。一名7岁的女性患者患有6年持续6年的流鼻涕和经常发生的咳嗽,持续2年的痰。通过诊断测试(如鼻氮氧化物(NO)浓度和透射电子显微镜等诊断测试,以及在进行诊断的其他考试之后诊断Karteragener综合症,例如计算机断层扫描,支气管镜检查和听力测试。对患者和父母进行全面测序。儿科患者被诊断为Kartergener综合征,睫状瘤患者的典型症状包括支气管扩张,鼻窦炎,导电性听力丧失和SITUS逆变以及降低的鼻腔没有浓度和睫状体异常。患者在DNAH5,NM_001369:C.12813G中携带两种新化合物的杂合酶突变:C.12813G?A(p。TRP4271TERM)和NM_001369:C.9365DELT(p。LEU3122TERM)。两个突变都导致过早的止损密码子,因此是致病性的。 p。 trp4271term和p。 Leu3122Term突变是单独从父亲和患者的母亲继承的。还进行了文献综述,总结了不同族裔综合征的小儿蛋白综合征的儿科患者DNAH5突变。我们的研究提供了使用一系列诊断测试与遗传检测结合的儿科患者在儿科患者中诊断kartergener综合征的一个很好的例子。鉴定了DNAH5中的两种新功能突变突变并验证了Kartericer综合征的儿科患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号